THC BioMed Executes Definitive Agreement
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/16/15 -- THC BioMed Intl Ltd. ("THC") (CSE: THC)(OTC PINK: THCBF)(FRANKFURT: TFHC) is pleased to announce it has Executed a Definitive agreement, as per the terms of the Binding Letter Agreement announced May 15th 2015, (the "Agreement") with Trans-Medica Ltd. ("Trans-Medica"), to provide consulting services and utilize Trans-Medica''s proprietary Vertical Grow System for total consideration to THC of $700,000.
Pursuant to the Agreement, THC will immediately supply consulting services to Trans-Medica to assist Trans-Medica in obtaining its own Producer''s License under Canada''s Marijuana for Medical Purposes Regulations (the "MMPR").
If THC acquires an MMPR Producer''s License, it will allocate a minimum of 25% of its growing facility to grow medical marijuana using the Vertical Grow Technology ("Vertical Marijuana"), sell and brand the Vertical Marijuana (the "Brand") and supply it to Trans-Medica''s estimated 3,000 patients for a 3-year term with an option to extend for an additional 2 years by making a onetime $200,000 payment.
Trans-Medica will pay to THC a total of $500,000 (the "Consideration") for the THC''s services under the Agreement, in three payments as follows:
Also, pursuant to the Agreement, THC will allocate the Consideration as follows:
John Miller, President of THC BioMed Intl Ltd. states, "We are very optimistic, as we begin to integrate the different verticals of this rapidly growing industry. We look forward to working with Trans-Medica and we are excited at the opportunity to work with their proprietary Vertical Grow System. Through the execution of well-designed experiments, THC''s scientific team will conduct validation processes in ensuring a standardized and effective product. With our vision of becoming fully licensed under the MMPR, we look forward to registering and supplying Trans-Medica''s estimated 3000 patients."
Trans-Medica is a private Ontario based company with extensive lateral relationships in all aspects of the burgeoning medical marijuana space, from growth and growing systems to clinicians and prescription.
THC''s vision is to be on the leading edge of scientific research and development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.
Please visit our website for a more detailed description of our business and services available.
Forward-Looking Information:
This press release contains certain "forward-looking information" within the meaning of applicable securities law. The forward looking statements include that (i) THC will assist Trans-Medica in obtaining its own MMPR Producer''s License, (ii) THC will supply the services and option to Trans-Medica as described above, (iii) Trans-Medica will pay a total of $700,000 to THC and (iv) THC will allocate the consideration as described above. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. These statements are based on expectations and assumptions made by the management of THC at the date the information is provided, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing THC and its business and affairs, readers should refer to THC''s Listing Statement, Financial Statements and its Management''s Discussion and Analysis on .
Contacts:
THC BioMed Intl Ltd.
John Miller
President and CEO
604 682-1643
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 16.07.2015 - 06:00 Uhr
Sprache: Deutsch
News-ID 1372686
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
VANCOUVER, BRITISH COLUMBIA
Phone:
Kategorie:
Mining & Metals
Anmerkungen:
Diese Pressemitteilung wurde bisher 131 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"THC BioMed Executes Definitive Agreement
"
steht unter der journalistisch-redaktionellen Verantwortung von
THC BioMed Intl Ltd. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
